Raymond James Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.28M	Sell	20,097 -40	-0.2%	-$4.55K	﹤0.01%	2971
2025 Q1	$2.12M	Sell	20,137 -1,693	-8%	-$178K	﹤0.01%	2942
2024 Q4	$2.34M	Buy	+21,830	New	+$2.34M	﹤0.01%	2849